Hit discovery of 4-amino-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide: A novel EGFR inhibitor from a designed small library
- Authors
- Elkamhawy, Ahmed; Paik, Sora; Hassan, Ahmed H. E.; Lee, Yong Sup; Roh, Eun Joo
- Issue Date
- 2017-11
- Publisher
- ACADEMIC PRESS INC ELSEVIER SCIENCE
- Citation
- BIOORGANIC CHEMISTRY, v.75, pp.393 - 405
- Abstract
- Searching for hit compounds within the huge chemical space resembles the attempt to find a needle in a haystack. Cheminformatics-guided selection of few representative molecules of a rationally designed virtual combinatorial library is a powerful tool to confront this challenge, speed up hit identification and cut off costs. Herein, this approach has been applied to identify hit compounds with novel scaffolds able to inhibit EGFR kinase. From a generated virtual library, six 4-aryloxy-5-aminopyrimidine scaffold-derived compounds were selected, synthesized and evaluated as hit EGFR inhibitors. 4-Aryloxy-5-benzamidopyrimidines inhibited EGFR with IC50 1.05-5.37 mu M. Cell-based assay of the most potent EGFR inhibitor hit (10ac) confirmed its cytotoxicity against different cancerous cells. In spite of no EGFR, HER2 or VEGFR1 inhibition was elicited by 4-aryloxy-5-(thio)ureidopyrimidine derivatives, cell-based evaluation suggested them as antiproliferative hits acting by other mechanism(s). Molecular docking study provided a plausible explanation of incapability of 4-aryloxy-5-(thio) ureidopyrimidines to inhibit EGFR and suggested a reasonable binding mode of 4-aryloxy-5-benzamidopyrimidines which provides a basis to develop more optimized ligands. (C) 2017 Elsevier Inc. All rights reserved.
- Keywords
- CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; UNIVERSE DATABASE GDB-17; TUMOR HETEROGENEITY; TARGETED THERAPY; SMALL MOLECULES; RECEPTOR; RESISTANCE; SPACE; VISUALIZATION; CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; UNIVERSE DATABASE GDB-17; TUMOR HETEROGENEITY; TARGETED THERAPY; SMALL MOLECULES; RECEPTOR; RESISTANCE; SPACE; VISUALIZATION; Antiproliferative hits; EGFR inhibitors; Phenotypic screening; Anticancer cell lines assay; Pyrimidine derivatives
- ISSN
- 0045-2068
- URI
- https://pubs.kist.re.kr/handle/201004/122132
- DOI
- 10.1016/j.bioorg.2017.10.009
- Appears in Collections:
- KIST Article > 2017
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.